David Harding, senior vice president, pipeline product management at Exact Sciences, joins HealthLeaders for a discussion on how to help health system leaders understand the foundation of Multi-Cancer Early Detection (MCED) and how it can impact cancer diagnosis, drive innovation and improve patient outcomes.

Information presented is not clinical, diagnostic, or treatment advice for any particular patient. Providers should use their clinical judgement and experience when deciding how to diagnose or treat patients. Exact Sciences does not recommend or endorse any particular course of treatment or medical choice.

Unlocking the Potential of Multi-Cancer Early Detection

The healthcare industry’s leading source for news, intelligence, and strategy for senior executives.

Unlocking the Potential of Multi-Cancer Early Detection

HealthLeaders Podcast